VarCov Co’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,895
Closed -$537K – 561
2026
Q2
$537K Sell
12,895
-2,578
-17% -$94.8K 0.2% 174
2026
Q1
$484K Buy
+15,473
New +$435K 0.18% 214

Other funds holding RAPP

VarCov Co's RAPP Position: Q3 2026 in Review

VarCov Co sold out of Rapport Therapeutics (RAPP) in Q3 2026, closing a stake of 12,895 shares — an estimated $537K sold.

VarCov Co first reported a position in RAPP in Q1 2026 and held it in 2 quarters. The position peaked at $537K in Q2 2026. 169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • VarCov Co reported no remaining Rapport Therapeutics position as of Q3 2026 after selling out during the quarter.
  • VarCov Co sold 12,895 Rapport Therapeutics shares in Q3 2026, an estimated $537K.
  • VarCov Co first reported a position in Rapport Therapeutics in Q1 2026 and held it in 2 quarters.
  • VarCov Co's Rapport Therapeutics position peaked at $537K in Q2 2026.
  • 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.